News
BRIDGEWATER, NJ / ACCESS Newswire / May 19, 2025 / Tharimmune, Inc. (Nasdaq:THAR), a clinical-stage biopharmaceutical company focused on developing innovative therapeutics, today announced the ...
"We are honored to welcome James Gordon Liddy to our team as a strategic advisor," said Vincent LoPriore, Executive Chairman of Tharimmune. "His extensive background in counter-terrorism ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results